Please login to the form below

Not currently logged in
Email:
Password:

Ritter Pharmaceuticals appoints new CMO

AnnKatrin Petersen-Jappelli to strengthen company

Ritter Pharmaceuticals has appointed AnnKatrin Petersen-Jappelli as chief medical officer.

Ritter is currently developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases.

Michael Step, CEO of Ritter Pharmaceuticals, said: “The additions of Dr Petersen-Jappelli further strengthens Ritter Pharmaceuticals' management with a leader who has significant experience in both the biotech and pharmaceutical industries, with a focus on treating gastrointestinal diseases.

Petersen-Jappelli joins Ritter having spent over 25 years in the pharmaceutical and biotechnology industry. Before this she served at Santarus as scientific research and clinical development leader of a phase III program for traveler's diarrhoea.

She said: “Joining Ritter Pharmaceuticals is an exciting opportunity to be part of a unique and innovative company that is working to treat gastrointestinal disease through the modulation of the gut microbiome.

“I believe my experience in product development coupled with my research capabilities will be a great combination for this role and I look forward to working with the team as we advance our science, build our product portfolio, and bring therapeutics to market that have the potential to provide significant relief to patients suffering from gastrointestinal diseases.”

9th October 2015

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics